Julie Sanders

Ms. Julie Sanders

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2023 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
Henriqueta LouroHenriqueta Louro
Henriqueta Louro
AVAriane Vettorazzi
Ariane Vettorazzi
ACAdela Lopez De Cerain
Adela Lopez De Cerain
ASAnastasia Spyropoulou
Anastasia Spyropoulou
ASAnita solhaug
Anita solhaug
Doris MarkoDoris Marko
Doris Marko
Fungi of the genus Alternaria are ubiquitous plant pathogens and saprophytes which are able to grow under varying temperature and moisture conditions as well as on a large range of substrates. A spectrum of structurally diverse secondary metabolites with toxic potential has been identified, but occurrence and relative proportion of the different metabolites in complex mixtures depend on strain, substrate, and growth conditions. This review compiles the available knowledge on hazard identification and characterization of Alternaria toxins. Alternariol (AOH), its monomethylether AME and the perylene quinones altertoxin I (ATX-I), ATX-II, ATX-III, alterperylenol (ALP), and stemphyltoxin III (STTX-III) showed in vitro genotoxic and mutagenic properties. Of all identified Alternaria toxins, the epoxide-bearing analogs ATX-II, ATX-III, and STTX-III show the highest cytotoxic, genotoxic, and mutagenic potential in vitro. Under hormone-sensitive conditions, AOH and AME act as moderate xenoestrogens, but in silico modeling predicts further Alternaria toxins as potential estrogenic factors. Recent studies indicate also an immunosuppressive role of AOH and ATX-II; however, no data are available for the majority of Alternaria toxins. Overall, hazard characterization of Alternaria toxins focused, so far, primarily on the commercially available dibenzo-α-pyrones AOH and AME and tenuazonic acid (TeA). Limited data sets are available for altersetin (ALS), altenuene (ALT), and tentoxin (TEN). The occurrence and toxicological relevance of perylene quinone-based Alternaria toxins still remain to be fully elucidated. We identified data gaps on hazard identification and characterization crucial to improve risk assessment of Alternaria mycotoxins for consumers and occupationally exposed workers.

26 March 2025 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
ABAnne-Cathrin Behr
Anne-Cathrin Behr
Christiane Kruse FæsteChristiane Kruse Fæste
Christiane Kruse Fæste
Amaya AzquetaAmaya Azqueta
Amaya Azqueta
ATAna M. Tavares
Ana M. Tavares
ASAnastasia Spyropoulou
Anastasia Spyropoulou
JDJessica Dietrich
Jessica Dietrich
Enniatins (ENNs) and beauvericin (BEA) are cyclic hexadepsipeptide fungal metabolites which have demonstrated antibiotic, antimycotic, and insecticidal activities. The substantial toxic potentials of these mycotoxins are associated with their ionophoric molecular properties and relatively high lipophilicities. ENNs occur extensively in grain and grain-derived products and are considered a food safety issue by the European Food Safety Authority (EFSA). The tolerable daily intake and maximum levels for ENNs in humans and animals remain unestablished due to key toxicological and toxicokinetic data gaps, preventing full risk assessment. Aiming to find critical data gaps impeding hazard characterization and risk evaluation, this review presents a comprehensive summary of the existing information from in vitro and in vivo studies on toxicokinetic characteristics and cytotoxic, genotoxic, immunotoxic, endocrine, reproductive and developmental effects of the most prevalent ENN analogues (ENN A, A1, B, B1) and BEA. The missing information identified showed that additional studies on ENNs and BEA have to be performed before sufficient data for an in-depth hazard characterisation of these mycotoxins become available.

14 March 2025 in Chemosensors
Verified
Journal Article
Open access
PDF file
JMJulien Masquelier
Julien Masquelier
ETEmmanuel K. Tangni
Emmanuel K. Tangni
PBPierre Becker
Pierre Becker
JSJulie Sanders
Julie Sanders
JLJoëlle Laporte
Joëlle Laporte
BMBirgit Mertens
Birgit Mertens
Mycotoxins are naturally occurring secondary metabolites produced by specific fungal strains. They can cause adverse effects, posing a serious health threat to both humans and livestock. Focusing on several mycotoxins, this study first aimed at optimizing and validating an ultra-high liquid chromatography-tandem mass spectrometry quantification method. This method was then applied to evaluate the production of the targeted mycotoxins in maize cultivated in the presence of Aspergillus spp., Fusarium spp., and Alternaria spp. The limits of detection of the analytical method for the different mycotoxins ranged between 0.5 and 200 μg kg−1, while the limits of quantification were between 1 and 400 μg kg−1. The linearities of the calibration curves were evaluated, with calculated R2 values above 0.99. The mean recoveries fell within the acceptable range of 74.0–106.0%, the repeatability was not higher than 14.4% RSD, and the highest intra-laboratory reproducibility was 16.2% RSD. The expanded measurement uncertainties ranged between 4.0% and 54.7%. Several fungal strains cultivated on maize grains were demonstrated to produce the targeted toxins, with production at µg kg−1 to mg kg−1 levels for aflatoxins and up to g kg−1 levels for fumonisins, zearalenone, and alternariol.

1 September 2022 in Mutagenesis
Verified
Journal Article
Closed access
PDF file
JSJulie Sanders
Julie Sanders
ATAnouck Thienpont
Anouck Thienpont
RARoel Anthonissen
Roel Anthonissen
TVTamara Vanhaecke
Tamara Vanhaecke
BMBirgit Mertens
Birgit Mertens
Previous studies have shown that differences in experimental design factors may alter the potency of genotoxic compounds in in vitro genotoxicity tests. Most of these studies used traditional statistical methods based on the lowest observed genotoxic effect levels, whereas more appropriate methods, such as the benchmark dose (BMD) approach, are now available to compare genotoxic potencies under different test conditions. We therefore investigated the influence of two parameters, i.e. cell type and exposure duration, on the potencies of two known genotoxicants [aflatoxin B1 and ethyl methanesulfonate (EMS)] in the in vitro micronucleus (MN) assay and comet assay (CA). Both compounds were tested in the two assays using two cell types (i.e. CHO-K1 and TK6 cells). To evaluate the effect of exposure duration, the genotoxicity of EMS was assessed after 3 and 24 h of exposure. Results were analyzed using the BMD covariate approach, also referred to as BMD potency ranking, and the outcome was compared with that of more traditional statistical methods based on lowest observed genotoxic effect levels. When comparing the in vitro MN results obtained in both cell lines with the BMD covariate approach, a difference in potency was detected only when EMS exposures were conducted for 24 h, with TK6 cells being more sensitive. No difference was observed in the potency of both EMS and aflatoxin B1 in the in vitro CA using both cell lines. In contrast, EMS was more potent after 24 h exposure compared with a 3 h exposure under all tested conditions, i.e. in the in vitro MN assay and CA in both cell lines. Importantly, for several of the investigated factors, the BMD covariate method could not be used to confirm the differences in potencies detected with the traditional statistical methods, thus highlighting the need to evaluate the impact of experimental design factors with adequate approaches.

12 May 2022 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
SMStacey Matthews
Stacey Matthews
ABAmanda Buttery
Amanda Buttery
AOAdrienne O’nEil
Adrienne O’nEil
JSJulie Sanders
Julie Sanders
SMSilvana Marasco
Silvana Marasco
RWRochelle Wynne
Rochelle Wynne
Aim: Reports of sex-specific differences in mortality after coronary artery bypass graft surgery (CABGS) are contradictory. The review aim was to determine whether CABGS is differentially efficacious than alternative procedures by sex, on short- and longer-term mortality. Methods and results: EMBASE, CINAHL, Medline, and the Cochrane Library were searched. Inclusion criteria: English language, randomized controlled trials from 2010, comparing isolated CABGS to alternative revascularization. Analyses were included Mantel–Haenszel fixed-effects modelling, risk of bias (Cochrane RoB2), and quality assessment (CONSORT). PROSPERO Registration ID: CRD42020181673. The search yielded 4459 citations, and full-text review of 29 articles revealed nine studies for inclusion with variable time to follow-up. Risk of mortality for women was similar in pooled analyses [risk ratio (RR) 0.94, 95% confidence interval (CI) 0.84–1.05, P = 0.26] but higher in sensitivity analyses excluding ‘high risk’ patients (RR 1.22, 95% CI 1.01–1.48, P = 0.04). At 30 days and 10 years, in contrast to men, women had an 18% (RR 0.82, 95% CI 0.66–1.02, P = 0.08) and 19% (RR 0.81, 95% CI 0.69–0.95, P = 0.01) mortality risk reduction. At 1–2 years women had a 7% (RR 1.07, 95% CI 0.69–1.64, P = 0.77), and at 2–5 years a 25% increase in risk of mortality compared with men (RR 1.25, 95% CI 1.03–1.53, P = 0.03). Women were increasingly under-represented over time comprising 41% (30 days) to 16.7% (10 years) of the pooled population. Conclusion: Meta-analysis revealed inconsistent sex-specific differences in mortality after CABGS. Trials with sex-specific stratification are required to ensure appropriate sex-differentiated treatments for revascularization.

13 February 2025 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
JSJulie Sanders
Julie Sanders
RARoel Anthonissen
Roel Anthonissen
GJGeorge Johnson
George Johnson
TVTamara Vanhaecke
Tamara Vanhaecke
BMBirgit Mertens
Birgit Mertens
Chemical risk assessment has historically focused on single compounds, neglecting the implications of combined exposures. To bridge this gap, several methodologies, such as concentration addition (CA) and independent action (IA), have been developed. However, a systematic, consistent, and integrated approach across various legislative frameworks is still lacking. The assessment of combined effects of genotoxicants is even more challenging, as genotoxicity data are typically evaluated qualitatively, without considering the effect size. This study aimed to develop a quantitative approach for evaluating the combined effects of genotoxic compounds with both similar and dissimilar modes of action (MoA), based on the benchmark concentration (BMC) principle. A proof-of-concept study was conducted using the in vitro micronucleus (MNvit) test to examine two types of binary mixtures: ethyl methanesulfonate (EMS) and methyl methanesulfonate (MMS), which share similar MoA, and MMS and etoposide (ETP), which have dissimilar MoA. The methodology involved collecting data for individual compounds, calculating BMC values, composing mixtures with different ratios and inducing various effect levels, testing these mixtures, and comparing the experimental results with the modelled data to verify additivity. The findings indicated that for both mixtures, the experimental responses aligned with the predicted additive effects, supporting the validity of the additivity principle. This study highlights the potential of an optimized BMC-based approach as a robust framework for testing chemical mixtures. It should be adopted in future studies to evaluate a wider range of genotoxic compounds, offering a more comprehensive and quantitative strategy for assessing combined chemical exposures.